Document:

Exhibit 10.4

 

EXECUTION VERSION

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement
(this “Subscription Agreement”), dated as of [●], 2019 is made and entered into by and between New Frontier
Corporation, a Cayman Islands exempted company (the “Company”), and the investor named on the signature page
hereof (“Investor”). Capitalized terms used but not otherwise defined in this Subscription Agreement have the
respective meanings given to them in the Transaction Agreement (as defined below).

 

WHEREAS, concurrently
with the execution and delivery of this Subscription Agreement, the Company and certain other parties are entering into that certain
Transaction Agreement, dated on or about the date hereof (as may be amended, supplemented, modified or varied from time to time,
the “Transaction Agreement”) relating to a proposed business combination involving the Company, Healthy Harmony
Holdings, L.P. (“HHH”) and/or their respective Affiliates to be effected on the terms and subject to the conditions
set forth in the Transaction Agreement (the “Business Combination Transaction”);

 

WHEREAS, in connection
with the Business Combination Transaction, Investor desires to subscribe for and purchase from the Company, and the Company desires
to allot and issue and sell to Investor, at the Closing (as defined below), the number of Class A ordinary shares, par value US$0.0001
per share, of the Company (the “Class A Ordinary Shares”) specified on the signature page hereof (as may be
adjusted in accordance with the terms herein, the “Subject Shares”) for the aggregate purchase price specified
on the signature page hereof (as may be adjusted in accordance with the terms herein, the “Purchase Price”),
representing a purchase price of  US$10.00 per Subject Share (the “Per Share Purchase Price”); and

 

WHEREAS, the Subject
Shares are being allotted and issued as part of a private placement by the Company of Class A Ordinary Shares (the “Private
Placement”).

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual representations, warranties, covenants and agreements, and subject to the conditions,
contained in this Subscription Agreement, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

 

Section 1.             Subscription
for Shares; Adjustment of Subject Shares and Purchase Price.

 

(a)             On
the terms and subject to the conditions contained in this Subscription Agreement, Investor hereby irrevocably subscribes for and
agrees to purchase from the Company, and the Company hereby agrees to allot and issue and sell to Investor, at the Closing, the
Subject Shares for the Purchase Price.

 

(b)             Notwithstanding
anything to the contrary, in the event that the Company determines in its sole discretion to issue fewer Class A Ordinary Shares
in connection with the Private Placement than the total number of Class A Ordinary Shares which Investor and other investors have
agreed to subscribe for as specified on the signature page(s) to this Subscription Agreement and other subscription agreements
entered into in connection therewith, the Company shall have the right to, by written notice to Investor at any time prior to ten
(10) Business Days before the Closing, reduce the number of Subject Shares by up to 25% and reduce the Purchase Price proportionally
based on the Per Share Purchase Price.

 

    	 	1	 

     

    

  

(c)             Investor’s
agreement and obligation to purchase the Subject Shares hereunder, and the obligations of other investors to purchase Class A Ordinary
Shares in the Private Placement, shall be several (and not joint and several). In no event shall Investor be obligated to purchase
any shares of the Company in any amount in excess of the Purchase Price.

 

Section 2.             Closing.

 

(a)             Subject
to the satisfaction or waiver of the conditions set forth in Section 4, the closing of the purchase and sale of the
Subject Shares contemplated hereby (the “Closing”) shall occur on the date (the “Closing Date”)
of, and immediately prior to the closing of the Business Combination Transaction as set forth in the Transaction Agreement. Not
less than fifteen (15) Business Days prior to the anticipated Closing Date, the Company shall deliver written notice (the “Closing
Notice”) to Investor specifying the anticipated Closing Date, as determined by the Company in good faith, and instructions
for wiring the Purchase Price to an account of a third-party escrow agent (the “Escrow Account”) which shall
be the Company’s transfer agent (the “Escrow Agent”) pursuant to an escrow agreement between the Company
and the Escrow Agent (the “Escrow Agreement”) in form and substance reasonably acceptable to Investor, a copy
of which shall be provided to Investor at least ten (10) Business Days before the Closing Date.

 

(b)             At
least five (5) Business Days before the Closing Date, subject to the satisfaction or waiver of the conditions set forth in Section 4
(other than those conditions that by their nature are to be satisfied at the Closing, but without affecting the requirement that
such conditions be satisfied or waived at the Closing), Investor shall deliver the Purchase Price in cash via wire transfer to
the Escrow Account as specified by the Company in the Closing Notice, to be held in escrow pending the closing of the Business
Combination Transaction. If the closing of the Business Combination Transaction does not occur within thirty (30) days after the
Closing Date specified in the Closing Notice, the Escrow Agreement will provide that the Escrow Agent shall, and the Company shall
cause the Escrow Agent to, automatically return to Investor the Purchase Price, provided that the return of the Purchase
Price placed in escrow shall not terminate the Agreement or otherwise relieve either party of any of its obligations hereunder,
further provided that the Company shall keep Investor reasonably informed of the status of the closing of the Business Combination
Transaction during such period before the return of the Purchase Price.

 

[(b)           On
or prior to 8:00 A.M. eastern time (or as soon as practicable after the Company or its transfer agent provides a screenshot evidencing
the issuance to Investor of the Subject Shares on and as of the Closing Date) on the Anticipated Closing Date specified in the
Closing Notice to Investor (or such other date as mutually agreed by the Company and the Investor), subject to the satisfaction
or waiver of the conditions set forth in Section 4 (other than those conditions that by their nature are to be satisfied at the
Closing, but without affecting the requirement that such conditions be satisfied or waived at the Closing), Investor shall deliver
the Purchase Price in cash via wire transfer to the Escrow Account as specified by the Company in the Closing Notice against delivery
by the Company to Investor of (i) the Subject Shares in book entry form, free and clear of any liens or other restrictions whatsoever
(other than those arising under state or federal securities laws), in the name of Investor (or its nominee in accordance with its
delivery instructions) or to a custodian designated by Investor, as applicable, and (ii) written notice from the Company or its
transfer agent evidencing the issuance to Investor of the Subject Shares on and as of the Closing Date. In the event that the Closing
does not occur within one (1) business day after the Anticipated Closing Date specified in the Closing Notice, the Company shall
promptly (but in no event later than two (2) business days after the Anticipated Closing Date specified in the Closing Notice (or
such other date as mutually agreed by the Company and the Investor)) return the funds so delivered by Investor to the Company by
wire transfer of United States dollars in immediately available funds to the account specified by Investor.]1

 

 

1 Included in the
subscription agreement for one investor.

 

    	 	2	 

     

    

  

(c)            On
the Closing Date, subject to the satisfaction or waiver of the conditions set forth in Section 4, the Company shall
instruct its registered office provider to register Investor as the owner of the Subject Shares purchased hereunder in the Company’s
register of members and deliver (or cause to be delivered) to Investor a certified copy of the Company’s updated register
of members against release by the Escrow Agent to the Company of the Purchase Price as provided in Section 2(b).

 

(d)            The
Company’s updated register of members shall contain a notation, and each certificate (if any) evidencing the Subject Shares
shall be stamped or otherwise imprinted with a legend, in substantially the following form:

 

“THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS
OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT OR LAWS.”

 

(e)             At
the Closing, the parties hereto shall execute and deliver, or cause to be executed and delivered, such additional documents and
take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the Closing
as contemplated by this Subscription Agreement.

 

Section 3.             Use
of Proceeds. The proceeds from the sale of the Subject Shares shall be used by the Company for the consummation of the Business
Combination Transaction in accordance with the Transaction Agreement, and any remaining balance may be used as directed by the
NFC Board.

 

Section 4.             Closing
Conditions.

 

(a)             The
obligations of each of the Company and Investor to consummate the Closing are subject to the satisfaction on the Closing Date,
or the waiver by each of the Company and Investor, of each of the following conditions:

 

(i)          all
conditions precedent to the closing of the Business Combination Transaction provided for in the Transaction Agreement shall have
been satisfied or waived by the applicable party or parties thereto (other than those conditions, which, by their nature, are to
be satisfied at the closing of the Business Combination Transaction, but subject to satisfaction of such conditions as of the closing
of the Business Combination Transaction [and provided that any such waiver does not materially adversely affect Investor]2),
and the closing of the Business Combination Transaction shall occur, in accordance with the terms of the Transaction Agreement,
on the Closing Date substantially concurrently with the Closing, without giving effect to any modifications, amendments, consents
or waivers of any provision thereof in any manner that result in, or would reasonably be expected to result in, a Material Adverse
Effect (as defined below) to the Company without the prior written consent (not to be unreasonably withheld, delayed or conditioned)
of Investor;

 

 

2 Included in the subscription agreement for one
investor.

 

    	 	3	 

     

    

  

(ii)         there
shall not be any law, order, writ, injunction, decree, determination or award of any governmental, regulatory, or administrative
authority or any court, tribunal, or judicial, or arbitral body having jurisdiction restraining, enjoining or otherwise prohibiting
or making illegal the consummation of the transactions contemplated by this Subscription Agreement; and

 

(iii)        the
Subject Shares shall have been approved for listing on the New York Stock Exchange (the “NYSE”), subject only
to official notice of issuance thereof, and no suspension of the qualification of the Subject Shares for offering or sale or trading
in the United States, New York or the NYSE, or initiation or threatening of any proceedings for any of such purposes, shall have
occurred.

 

(b)            In
addition to the conditions set forth in Section 4(a), the obligation of Investor to consummate the Closing is subject
to the satisfaction on the Closing Date, or the waiver by Investor, of the following conditions:

 

(i)          (A)
the representations and warranties of the Company set forth in Section 5(a), Section 5(b), Section 5(c),
Section 5(k) and Section 5(q) and those other representations and warranties of the Company set forth in
Section 5 that are qualified by any materiality or Material Adverse Effect qualifier shall be true and correct in all
respects at and as of the date of this Subscription Agreement and the Closing Date as if made at and as of the Closing Date (other
than those representations and warranties expressly made as of an earlier date, which shall be true and correct in all respects
as of such earlier date); and (B) the other representations and warranties of the Company set forth in Section 5 shall
be true and correct in all material respects at and as of the date of this Subscription Agreement and the Closing Date as if made
at and as of the Closing Date (other than those representations and warranties expressly made as of an earlier date, which shall
be true and correct in all material respects as of such earlier date);

 

(ii)         the
Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing; and

 

(iii)        Investor
shall have received a certificate dated as of the Closing Date, duly executed and delivered on behalf of the Company by the chief
executive officer of the Company certifying that the conditions set forth in Section 4(a)(i), Section 4(b)(i)
and Section 4(b)(ii) have been duly satisfied.

 

[(iv)      the
Transaction Agreement shall not have been amended to provide for a total enterprise value for all of the businesses to be acquired
therein (calculated on a cash-free, debt-free basis and assuming a normal amount of working capital) that is in excess of $1,330,000,000.]3

 

 

3 Included in the
subscription agreement for two investors.

 

    	 	4	 

     

    

  

[(iv)      the
aggregate number of ordinary shares of the Company issued and outstanding as of immediately prior to the closing of the Business
Combination (treating all ordinary shares to be issued pursuant to the Private Placement (as may be adjusted pursuant to the cut-back
arrangements therein) as issued and outstanding for such purposes) shall not exceed 149,000,000.]4

 

(c)            In
addition to the conditions set forth in Section 4(a), the obligation of the Company to consummate the Closing is subject
to the satisfaction on the Closing Date, or the waiver by the Company, of the following conditions:

 

(i)          (A)
the representations and warranties of Investor set forth in Section 6(a) and Section 6(b) and those other
representations and warranties of Investor set forth in Section 6 that are qualified by any materiality or Material
Adverse Effect qualifier shall be true and correct in all respects at and as of the date of this Subscription Agreement and the
Closing Date (other than those representations and warranties expressly made as of an earlier date, which shall be true and correct
in all respects as of such earlier date); and (B) the other the representations and warranties of Investor set forth in Section 6
shall be true and correct in all material respects at and as of the date of this Subscription Agreement and the Closing Date (other
than those representations and warranties expressly made as of an earlier date, which shall be true and correct in all material
respects as of such earlier date); and

 

(ii)         Investor
shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
this Subscription Agreement to be performed, satisfied or complied with by Investor at or prior to the Closing.

 

Section 5.             The
Company’s Representations and Warranties. The Company represents and warrants to Investor
that, as of the date hereof and as of the Closing Date:

 

(a)             The
Company has been duly incorporated, is validly existing and is in good standing as an exempted company under the laws of the Cayman
Islands, with the corporate power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

(b)             The
Subject Shares have been duly authorized and, when allotted and issued and delivered to Investor against full payment of the Purchase
Price in accordance with the terms of this Subscription Agreement, will be validly issued, fully paid and non-assessable and will
not have been issued in violation of, or subject to any preemptive or similar rights created under the Company’s organizational
documents or under the laws of the Cayman Islands. As of the Closing, the Subject Shares shall be identical in all respects to
the Company’s outstanding publicly traded shares other than that the Subject Shares have not been registered under the Securities
Act (as hereinafter defined).

 

 

4 Included in the
subscription agreement for one investor.

 

    	 	5	 

     

    

 

(c)             The
execution, delivery and performance of its obligations by the Company of this Subscription Agreement and the consummation of the
transactions contemplated hereby have been duly and validly authorized by all requisite corporate action, and no other proceedings
on the Company’s part are necessary to authorize the execution, delivery or performance of its obligations by the Company
of this Subscription Agreement. This Subscription Agreement has been duly executed and delivered by the Company, constitutes a
valid and binding obligation of the Company and is enforceable against the Company in accordance with its terms, except as may
be limited or otherwise affected by (i) bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar
laws relating to or affecting the rights of creditors generally, (ii) applicable laws relating to the availability of specific
performance, injunctive relief or other equitable remedies, or (iii) to the extent the indemnification provisions contained in
the Registration Rights may be limited by applicable federal or state securities laws.

 

(d)             The
execution and delivery by the Company of this Subscription Agreement, and the performance by the Company of its obligations under
this Subscription Agreement, including the allotment and issue and sale of the Subject Shares, do not and will not conflict with
or result in a breach or violation of any of the terms or provisions of, or constitute a default under, require any notice, filing,
consent, authorization or approval under, or result in the creation or imposition of any lien, charge or encumbrance upon any of
the property or assets of the Company or pursuant to the terms of  (i) any indenture, mortgage, deed of trust, loan agreement,
license, lease or any other agreement, contract or instrument to which the Company is a party or by which the Company is bound
or to which any of the property or assets of the Company is subject; (ii) the organizational documents of the Company; or (iii)
any statute or any judgment, order, injunction, award, decree, law, code, rule or regulation of any court, arbitral, regulatory,
administrative or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties,
except, in the case of clause (i), for such matters that would not, individually or in the aggregate, reasonably be expected to
have a material adverse effect on the business, properties, assets, liabilities, financial condition, shareholders’ equity
or results of operations of the Company and its subsidiaries, taken as a whole (for such purposes, treating the Business Combination
Transaction as having been consummated), the validity of the Subject Shares or the legal authority or ability of the Company to
perform in all material respects its obligations under the Transaction Agreement or this Subscription Agreement (a “Material
Adverse Effect”).

 

(e)             Assuming
the accuracy of the representations and warranties of Investor set forth in Section 6(e), Section 6(f),
Section 6(i) through Section 6(m) and Section 6(p), in connection with the offer, sale and
delivery of the Subject Shares in the manner contemplated by this Subscription Agreement, it is not required to register the Subject
Shares under the Securities Act of 1933, as amended (the “Securities Act”).

 

(f)              Neither
the Company nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general advertising
(within the meaning of Regulation D of the Securities Act) in connection with any offer or share of the Subject Shares.

 

    	 	6	 

     

    

  

(g)             The
Company has timely and duly filed all forms, reports and other documents required to be filed by it with the Securities and Exchange
Commission (the “SEC”), together with any amendments, restatements or supplements thereto (all of the foregoing
filed since June 27, 2018 and all exhibits included therein and financial statements and schedules thereto and documents incorporated
by reference therein, being hereinafter referred to herein as the “SEC Documents”) since June 27, 2018. As of
their respective dates, the SEC Documents complied in all material respects with the requirements of the Securities Act and the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), as the case may be, and the rules and regulations
thereunder, and none of the SEC Documents, at the time they were filed with the SEC (except to the extent that information contained
in any SEC Document has been superseded by a later timely filed SEC Document), contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading. There are no material outstanding or unresolved comments
in comment letters from the SEC with respect to any of the SEC Documents. Each of the financial statements (including, in each
case, any notes thereto) contained in the SEC Documents was prepared in accordance with generally accepted accounting principles
applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto or, in the case
of unaudited statements, as permitted by Form 10-Q of the SEC) and each fairly presents, in all material respects, the financial
position, results of operations and cash flows of the Company as at the respective dates thereof and for the respective periods
indicated therein.

 

(h)             Since
June 27, 2018, the Company has timely filed all certifications and statements required by (x) Rule 13a-14 or Rule 15d-14 under
the Exchange Act or (y) 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) with respect to any SEC Document
(the “Company Certifications”). Each of the Company Certifications is true and correct. The Company maintains
disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; such controls and procedures
are reasonably designed to ensure that all material information concerning the Company is made known on a timely basis to the individuals
responsible for the preparation of the Company’s SEC filings and other public disclosure documents. As used in this Section 5(h),
the term “file” shall be broadly construed to include any manner in which a document or information is furnished, supplied
or otherwise made available to the SEC.

 

(i)              The
Company is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute
a default or violation) of any term, condition or provision of  (i) any indenture, mortgage, deed of trust, loan agreement,
license, lease or any other agreement, contract or instrument to which the Company is a party or by which the Company is bound
or to which any of the property or assets of the Company is subject; (ii) the organizational documents of the Company; or (iii)
any statute or any judgment, order, injunction, award, decree, law, code, rule or regulation of any court, arbitral, regulatory,
administrative or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties,
except, in the case of clause (i), for defaults or violations that have not had and would not be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect.

 

(j)              The
Company is not required to obtain any consent, approval, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or
other person in connection with the execution, delivery and performance by the Company of this Subscription Agreement (including,
without limitation, the issuance of the Subject Shares), other than (i) filings required by applicable state or federal securities
laws, including Regulation D promulgated under the Securities Act and (ii) those required by the NYSE, including with respect to
obtaining shareholder approval [and (iii) the failure of which to obtain would not be reasonably likely to have, individually or
in the aggregate, a Material Adverse Effect]5.

 

 

5 Included in the
subscription agreement for one investor.

  

    	 	7	 

     

    

 

(k)             The
authorized share capital of the Company consists of: (i) 1,000,000 preference shares, par value US$0.0001 per share (the “Preference
Shares”); (ii) 180,000,000 Class A Ordinary Shares; and (iii) 20,000,000 Class B ordinary shares, par value US$0.0001
per share (the “Class B Ordinary Shares”). As of the date hereof and immediately prior to the Closing (prior
to giving effect to any valid redemption of Class A Ordinary Shares pursuant to the Company Charter or any issuance of Class A
Ordinary Shares hereunder or under the other subscription agreements and except as may be otherwise disclosed pursuant to the NFC
reports or to Investor in writing prior to the date hereof or prior to the Closing, as applicable): (i) no Preference Shares are
issued and outstanding, (ii) 28,750,000 Class A Ordinary Shares are issued and outstanding, (iii) 11,712,500 Class B Ordinary Shares
are issued and outstanding, and (iv) 22,125,000 warrants, each entitling the holder thereof to purchase one (1) Class A Ordinary
Share at an exercise price of $11.50 per share, are outstanding. Except (a) as set forth in the preceding sentence, (b) certain
Class A Ordinary Shares to be issued at the Closing pursuant to or as contemplated by the Transaction Agreement and/or the Ancillary
Agreements, (c) pursuant to this Subscription Agreement and other subscription agreements entered into in connection with the Private
Placement, or (d) pursuant to the forward purchase agreements as disclosed in, and in the form filed as Exhibit 3.2 to, the Registration
Statement on Form S-1 of the Company filed with the SEC on June 4, 2018 (collectively, the “Forward Purchase Agreements”),
the Company has no other commitments, side letters, agreements or understanding to issue or sell, directly or indirectly, any Class
A Ordinary Shares, Class B Ordinary Shares or outstanding options, warrants, convertible or exchangeable securities or other equity
interests in the Company or securities convertible into or exchangeable for equity interests of the Company.

 

(l)              The
Company has not received any written communication since June 27, 2018 from a governmental entity that alleges that the Company
is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation
would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.

 

(m)            The
issued and outstanding Class A Ordinary Shares are registered pursuant to Section 12(b) of the Exchange Act, and are listed for
trading on the NYSE. There is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened
against the Company by the NYSE or the SEC with respect to any intention by such entity to deregister the Class A Ordinary Share
or prohibit, terminate or suspend the listing of the Class A Ordinary Share on the NYSE. The Company has taken no action that is
designed to terminate the registration of the Class A Ordinary Share under the Exchange Act.

 

(n)             There
is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of the Company’s
officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

    	 	8	 

     

    

  

(o)             Neither
the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has, in the course of its
actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign
Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or
other unlawful payment to any foreign or domestic government official or employee. For purposes of this Subscription Agreement,
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity or any government or any department or agency thereof.

 

(p)             The
operations of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting
requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, but not limited
to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and the applicable
money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company,
threatened.

 

(q)             Other
than the Placement Agent, no broker, finder, investment banker or other Person is entitled to any brokerage, finder’s fee
or commission from the Company in connection with the Private Placement for which Investor would be liable.

 

(r)             With
respect to any offers or sales of Class A Ordinary Shares in reliance on Regulation S under the Securities Act, none of the Company,
any of its Affiliates (as defined in Rule 405 under the Securities Act) or any other Person acting on behalf of the Company has,
with respect to the Class A Ordinary Shares, offered the Class A Ordinary Shares to buyers qualifying as “U.S. persons”
(as defined in Rule 902 under the Securities Act) or in the United States or engaged in any “directed selling efforts”
within the meaning of Rule 902 under the Securities Act; the Company, any Affiliate of the Company and any Person acting on behalf
of the Company have complied with any applicable “offering restrictions” within the meaning of such Rule 902; provided
that no representation or warranty is made in this paragraph with respect to the actions of the Placement Agents (as defined below)
or any of their Affiliates.

 

[(s)            Except
as set forth in the SEC Documents, there are no securities or instruments issued by or to which the Company is a party containing
anti-dilution or similar provisions that will be triggered by the issuance of (i) the Subject Shares, or (ii) any other shares
to be issued as part of the Private Placement.

 

(t)             The
company is not, and immediately after receipt of payment for the Subject Shares will not be, an “investment company”
within the meaning of the Investment Company Act of 1940, as amended.

 

    	 	9	 

     

    

  

(u)             None
of the Company nor any of its subsidiaries, or to the actual knowledge of the Company, the directors, officers, agents, employees
or affiliates of the Company, is currently the target of, or otherwise subject to restrictions under, any sanctions administered
or enforced by the United States, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of
the Treasury (“OFAC”) or the U.S. Department of State; the United Nations Security Council; Canada; the European
Union; the United Kingdom; or other government authority with jurisdiction over the parties (collectively, “Sanctions”).
None of the Company or any of its subsidiaries, affiliates, or agents is located, organized or resident in a country or territory
that is the subject or target of country- or territory-wide Sanctions, including, without limitation, Crimea, Cuba, Iran, North
Korea or Syria (each, a “Sanctioned Country”). The Company and its subsidiaries, affiliates, or agents will
not directly or indirectly use the proceeds from the Subject Shares, or lend, or knowingly contribute or otherwise make available
such proceeds: (i) to fund or facilitate any activities of or business with any person that is the target of, or otherwise subject
to restrictions under, any Sanctions; (ii) to fund or facilitate any activities of or business in any Sanctioned Country; or (iii)
in any other manner that will result in a violation by any person (including any person participating in the transaction, whether
as underwriter, initial purchaser, advisor, investor or otherwise) of Sanctions. In the past five years, none of the Company nor
any of its subsidiaries, or to the actual knowledge of the Company, its affiliates, or agents have engaged in or are now engaged
in any dealings or transactions: (i) with, or involving the interests or property of, any person that, at the time of the dealing
or transaction, was or is subject to restrictions imposed by any Sanctions or located, organized or resident in a Sanctioned Country;
or (ii) that are otherwise prohibited by Sanctions.]6

 

Section 6.             Investor’s
Representations and Warranties. Investor represents and warrants to the Company that, as of the date hereof and as of the Closing
Date:

 

(a)             Investor
has been duly formed, is validly existing and is in good standing under the laws of its jurisdiction of formation (if the concept
of “good standing” is a recognized concept in such jurisdiction), with the requisite entity power and authority to
enter into, deliver and perform its obligations under this Subscription Agreement.

 

(b)             This
Subscription Agreement has been duly authorized, executed and delivered by Investor, constitutes a valid and legally binding obligation
of Investor, and is enforceable against Investor in accordance with its terms, except as may be limited or otherwise affected by
(i) bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws relating to or affecting the
rights of creditors generally, (ii) laws relating to the availability of specific performance, injunctive relief or other equitable
remedies, or (iii) to the extent the indemnification provisions contained in the Registration Rights may be limited by applicable
federal or state securities laws.

 

(c)             Other
than filings required by applicable state or federal securities laws, including Regulation D promulgated under the Securities Act,
no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of Investor in connection with the consummation of the transactions
contemplated by this Subscription Agreement.

 

 

6 Included in the
subscription agreement for one investor.

 

    	 	10	 

     

    

  

(d)             The
execution and delivery by Investor of this Subscription Agreement, and performance by Investor of its obligations under this Subscription
Agreement, including the purchase of the Subject Shares, do not and will not conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or
encumbrance upon any of the property or assets of Investor or pursuant to the terms of  (i) any indenture, mortgage, deed
of trust, loan agreement, lease, license or other agreement or instrument to which Investor is a party or by which Investor is
bound or to which any of the property or assets of Investor is subject; (ii) the organizational documents of Investor; or (iii)
any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having
jurisdiction over Investor or any of its properties, except, in the case of clauses (i) and (iii), for such matters that would
not reasonably be expected to have a material adverse effect on the legal authority or ability of Investor to perform its obligations
under this Subscription Agreement.

 

(e)             Investor
(i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the applicable requirements
set forth on Schedule I, or is not a “U.S. Person” as defined in Rule 902 of Regulation S under the Securities
Act, (ii) is acquiring the Subject Shares only for its own account and not for the account of others, or if Investor is subscribing
for the Subject Shares as a fiduciary or agent for one or more investor accounts, each owner of such account is a “qualified
institutional buyer” or an institutional “accredited investor” (each as defined above), and Investor has full
investment discretion with respect to each such account and the full power and authority to make the acknowledgements, representations
and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Subject Shares with a view to,
or for offer or sale in connection with, any distribution thereof in violation of the Securities Act and Investor further represents
that Investor does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or
grant participations in the Subject Shares to such Person or to any third Person, with respect to any of the Subject Shares. If
Investor was formed for the specific purpose of acquiring the Subject Shares, each of its equity owners is an accredited investor.
Investor has completed Schedule I hereto, and the information contained therein is accurate and complete.

 

(f)              Investor
understands that the Subject Shares are being offered in a transaction not involving any public offering within the meaning of
the Securities Act and that the Subject Shares have not been registered under the Securities Act. Investor understands that the
Subject Shares may not be resold, transferred, pledged or otherwise disposed of by Investor absent an effective registration statement
under the Securities Act, except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales
that occur outside the United States within the meaning of Regulation S under the Securities Act, (iii) pursuant to Rule 144 under
the Securities Act, provided that all of the applicable conditions thereof have been met, or (iv) pursuant to another applicable
exemption from the registration requirements of the Securities Act, and that any book-entry notations with respect to (or certificates
representing) the Subject Shares will contain a legend to such effect. Investor acknowledges that the Subject Shares will not be
eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Investor understands and agrees that the Subject
Shares, until transferred pursuant to an effective registration statement, will be subject to transfer restrictions and, as a result
of these transfer restrictions, Investor may not be able to readily resell the Subject Shares and may be required to bear the financial
risk of an investment in the Subject Shares for an indefinite period of time. Investor acknowledges that the Company has no obligation
to register or qualify the Subject Shares for resale, except for the Registration Rights. Investor understands that it has been
advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any of the Subject Shares.

 

    	 	11	 

     

    

  

(g)             Investor
understands and agrees that Investor is purchasing Subject Shares directly from the Company. Investor further acknowledges that
there have been no representations, warranties, covenants and agreements made to Investor by or on behalf of the Company (including
without limitation any placement agent for the sale of the Subject Shares), expressly or by implication, other than those representations,
warranties, covenants and agreements of the Company expressly set forth in this Subscription Agreement.

 

(h)             Investor’s
acquisition and holding of the Subject Shares will not constitute or result in a non-exempt prohibited transaction under Section
406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code, as amended (the
“Code”), or any applicable similar law.

 

(i)              In
making its decision to subscribe for and purchase the Subject Shares, Investor has relied solely upon Investor’s own independent
investigation and the representations and warranties of the Company contained herein. Investor acknowledges that (i) Investor has
received such information as Investor deems necessary in order to make an investment decision with respect to the Subject Shares,
and (ii) Investor and its professional advisor(s), if any, have had the full opportunity to ask the Company’s management
questions, receive such answers and obtain such information as Investor and its professional advisor(s), if any, have deemed necessary
to make an investment decision with respect to the Subject Shares. Investor acknowledges and agrees that neither Credit Suisse
Securities (USA) LLC / UBS Securities LLC, acting as placement agent to the Company (the “Placement Agent”), nor any
affiliate of the Placement Agent has provided Investor with any information or advice with respect to the Subject Shares nor is
such information or advice necessary or desired. Neither the Placement Agent nor any of its affiliates has made or makes any representation
as to the Company or HHH or the quality of the Subject Shares. In connection with the issuance of the Subject Shares to Investor,
neither the Placement Agent nor any of its affiliates has acted as a financial advisor or fiduciary to Investor.

 

(j)              Investor
became aware of the offering of the Subject Shares solely by means of direct contact between Investor and the Company or by means
of contact from the Placement Agent, and the Subject Shares were offered to Investor solely by direct contact between Investor
and the Company or by contact between Investor and the Placement Agent. Investor did not become aware of the offering of the Subject
Shares, nor were the Subject Shares offered to Investor, by any other means.

 

(k)             Investor
acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Subject Shares. Investor
has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment
in the Subject Shares, and Investor has sought such accounting, legal and tax advice as Investor has considered necessary to make
an informed investment decision.

 

(l)              Alone,
or together with any professional advisor(s), Investor has adequately analyzed and fully considered the risks of an investment
in the Subject Shares and determined that the Subject Shares are a suitable investment for Investor and that Investor is able at
this time and in the foreseeable future to bear the economic risk of a total loss of Investor’s investment in the Company.
Investor acknowledges specifically that a possibility of total loss exists.

 

    	 	12	 

     

    

  

(m)            Investor
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Subject Shares
or made any findings or determination as to the fairness of an investment in the Subject Shares.

 

(n)            Investor
is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons, the Executive Order 13599
List, or the Foreign Sanctions Evaders List, each of which is administered by the U.S. Treasury Department’s Office of Foreign
Assets Control (“OFAC”) or in any Executive Order issued by the President of the United States and administered
by OFAC (collectively, the “OFAC Lists”), or a person or entity prohibited by any OFAC sanctions program, (ii) a
Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a non-U.S. shell bank
or, to Investor’s knowledge, providing banking services indirectly to a non-U.S. shell bank. Investor agrees to provide law
enforcement agencies, if requested thereby, such records as required by applicable law, provided that Investor is permitted to
do so under applicable law. If Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.),
as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively,
the “BSA/PATRIOT Act”), Investor maintains policies and procedures reasonably designed to comply with applicable
obligations under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed for the
screening of its investors against the OFAC Lists. To the extent required, it maintains policies and procedures reasonably designed
to ensure that the funds held by Investor and used to purchase the Subject Shares were legally derived.

 

(o)             If
Investor is not a United States person (as defined by Section 7701(a)(30) of the Code), Investor hereby represents that it
has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for
the Subject Shares or any use of this Subscription Agreement, including (i) the legal requirements within its jurisdiction for
the purchase of the Subject Shares, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental
or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant
to the purchase, holding, redemption, sale, or transfer of the Subject Shares. Assuming the accuracy of the representations and
warranties of the Company set forth in Section 5, Investor’s subscription and payment for and continued beneficial
ownership of the Subject Shares will not violate any applicable securities or other laws of Investor’s jurisdiction.

 

(p)             If
Investor is an individual, then Investor resides in the state or province identified in the address of Investor set forth on the
signature page hereof; if Investor is a partnership, corporation, limited liability company or other entity, then its principal
place of business is the office or offices located at the address or addresses of Investor set forth on the signature page hereof.

 

(q)             Investor
acknowledges its obligations under applicable securities laws with respect to the treatment of material non-public information
relating to the Company.

 

(r)             Investor
has access to, and at the Closing will have, sufficient funds to pay the Purchase Price.

 

    	 	13	 

     

    

  

(s)             If
Investor is not a U.S. Person (as defined under Rule 902 under the Securities Act) and the offer and sale of the Subject Shares
is being made in reliance on Regulation S under the Securities Act, (i) Investor was or will be outside the United States at the
time any buy order for the Class A Ordinary Shares was or is originated, and (ii) neither Investor nor any of its Affiliates (as
defined in Rule 405 under the Securities Act) has, with respect to the Class A Ordinary Shares, engaged in any “directed
selling efforts” within the meaning of Rule 902 under the Securities Act.

 

Section 7.             No
other Representations or Warranties.

 

(a)             Except
for the specific representations and warranties contained in Section 5, none of the Company nor any person on behalf
of the Company, including without limitation any placement agent for the sale of the Subject Shares nor any of the Company’s
affiliates or representatives (collectively, the “Company Parties”) has made, makes or shall be deemed to make
any other express or implied representation or warranty with respect to the Company, HHH, the Business Combination Transaction,
the offering of the Subject Shares, the transaction contemplated hereby or any other matter, and the Company Parties disclaim any
such representation or warranty. Except for the specific representations and warranties expressly made by the Company in Section 5
and in any certificate or agreement delivered pursuant hereto, Investor specifically disclaims that it, or anyone on its behalf,
is relying upon any other representations or warranties that may have been made by any Company Party.

 

(b)             Except
for the specific representations and warranties contained in this Section 6, none of Investor nor any person acting
on behalf of Investor nor any of Investor’s affiliates (the “Investor Parties”) has made, makes or shall
be deemed to make any other express or implied representation or warranty with respect to Investor and the transactions contemplated
hereby, and the Investor Parties disclaim any such representation or warranty. Except for the specific representations and warranties
expressly made by Investor in Section 6, the Company specifically disclaims that it, or anyone on its behalf, is relying
upon any other representations or warranties that may have been made by any Investor Party.

 

Section 8.             Registration
Rights. Investor shall have registration rights as set forth on Exhibit A hereto (the “Registration Rights”).

 

Section 9.             Termination.   This
Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur
of  (a) such date and time as the Transaction Agreement is terminated in accordance with its terms, (b) upon the mutual
written agreement of each of the parties hereto to terminate this Subscription Agreement and the prior written consent of HHH,
(c) the closing of the Business Combination Transaction without the substantially concurrent consummation of the Closing as a
result of the failure of any of the conditions to the Closing set forth in Section 4 above to be satisfied or waived
at or prior to the Closing, (d) the Outside Date (as defined under the Transaction Agreement), (e) the entering into of an agreement
by HHH and/or its Affiliates with a third party other than the Company relating to a merger, acquisition, consolidation, business
combination or similar transaction involving, or any acquisition of all or a material portion of the business or assets of, HHH,
or (f) the failure of to consummate the Business Combination Transaction before July 3, 2020; provided that in the event
of any termination of this Agreement pursuant to this Section 9, the Purchase Price (and the interest accrued thereon),
if previously paid, shall be promptly (and in any event within one (1) business day) returned to the Purchaser and this Agreement
shall forthwith become null and void and have no effect, without any liability on the part of Investor or the Company and their
respective directors, officers, employees, partners, managers, members or shareholders and all rights and obligations of each
party shall cease; provided, however, that nothing herein will relieve any party from liability for any willful breach
hereof prior to the time of termination of this Subscription Agreement, and each party will be entitled to any remedies at law
or in equity to recover losses, liabilities or damages arising from such willful breach. The Company shall notify Investor in
writing of the termination of the Transaction Agreement promptly after such termination. Notwithstanding the foregoing, this Section 9,
Section 10 and Section 12 shall survive the termination of this Subscription Agreement.

 

    	 	14	 

     

    

  

Section 10.           Trust
Account Waiver. Investor hereby acknowledges that the Company has established a trust account (the “Trust Account”)
containing the proceeds of its initial public offering (the “IPO”) and from certain private placements occurring
simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of the Company’s public
shareholders (the “Public Shareholders”) and certain other parties (including the underwriters of the IPO).
For and in consideration of the Company entering into this Subscription Agreement, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, Investor hereby agrees that it does not now and shall not at any
time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust Account, and shall not
make any claim against the Trust Account, regardless of whether such claim arises as a result of, in connection with or relating
in any way to this Subscription Agreement or any other matter, and regardless of whether such claim arises based on contract, tort,
equity or any other theory of legal liability (any and all such claims are collectively referred to hereafter as the “Released
Claims”). Investor hereby irrevocably waives any Released Claims that it may have against the Trust Account now or in
the future as a result of, or arising out of, any discussions, contracts or agreements with the Company and will not seek recourse
against the Trust Account for any reason whatsoever. In the event Investor has any right, title, interest or claim of any kind
against the Company under this Agreement, Investor shall pursue such right, title, interest or claim solely against the Company
and its assets outside the Trust Account.

 

Section 11.           No
Waiver. The Company shall not waive any condition to the closing of the Business Combination Transaction as set forth
in the Transaction Agreement that results in, or would reasonably be expected to result in a Material Adverse Effect without the
prior written consent (not to be unreasonably withheld, delayed or conditioned) of Investor.

 

[Section 11.         Certain
Covenants.

 

(a)          The Company
shall not waive any condition to the closing of the Business Combination Transaction as set forth in the Transaction Agreement
that results in, or would reasonably be expected to result in a Material Adverse Effect without the prior written consent (not
to be unreasonably withheld, delayed or conditioned) of Investor.

 

(b)          The
Company will use reasonable efforts to determine whether it is a “passive foreign investment company” as defined in
Section 1297 of the Code (a “PFIC”). If the Company determines that it is a PFIC, it will (i) notify Investor of its
PFIC status and (ii) use reasonable efforts to provide information adequate for an election to be made treating NFC as a “qualified
electing fund” under Section 1295 of the Code.]7

 

 

7 Included in the
subscription agreement for two investors.

 

    	 	15	 

     

    

  

Section 12.           Miscellaneous.

 

(a)             Each
of the Company and Investor will bear its own costs and expenses incurred in connection with the preparation, execution and performance
of this Subscription Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of
agents, representatives, financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its
transfer agent, the Escrow Agent, stamp taxes and all of The Depository Trust Company’s fees associated with the issuance
of the Subject Shares.

 

(b)             This
Subscription Agreement and the rights and obligations of the parties hereunder may not be assigned by any party to any other person,
except that Investor may assign its rights and obligations under this Subscription Agreement to one or more of its affiliates or
another person acceptable to the Company, provided that no such assignment shall relieve Investor of its obligations
hereunder if any such affiliate fails to perform such obligations.

 

(c)             The
Company may request from Investor such additional information as the Company may reasonably deem necessary to evaluate the eligibility
of Investor to acquire the Subject Shares, and Investor shall provide such information as may reasonably be requested, to the extent
readily available and to the extent consistent with its internal policies and procedures.

 

(d)             Each
of the Company and Investor is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce this
Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with
respect to the matters covered hereby. The Placement Agent shall be a third party beneficiary of the representations and warranties
of the Company set forth in Section 5 hereof and with respect to the representations and warranties of Investor set
forth in Section 6 hereof. HHH shall have the right, as a third party beneficiary of Investor’s covenants contemplated
under this Subscription Agreement to obtain specific performance of, or cause the Company to seek specific performance of, Investor’s
obligations to deliver the Purchase Price in accordance with this Subscription Agreement. Nothing herein shall limit the rights
of HHH to make a claim under the Transaction Agreement against the Company.

 

(e)             All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

(f)              This
Subscription Agreement may not be amended, modified, waived or terminated except by an instrument in writing, signed by each of
the parties hereto and HHH.

 

    	 	16	 

     

    

  

(g)             This
Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations
and warranties, both written and oral, among the parties with respect to the subject matter hereof. For the avoidance of doubt,
this Subscription Agreement shall not have the effect of superseding or supplementing (or otherwise affect) the Forward Purchase
Agreements. This Subscription Agreement is exclusively for the benefit of the parties hereto, and their respective successors and
permitted assigns, and except as provided in Section 12(d), this Subscription Agreement shall not be deemed to confer
upon or give to any other third party any remedy, claim, liability, reimbursement, cause of action or other right, in each case
whether by virtue of the Contracts (Rights of Third Parties) Ordinance (Cap. 623 of the Laws of Hong Kong) or any similar law in
other jurisdiction to enforce any of the terms to this Subscription Agreement.

 

(h)             Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

(i)              If
any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability
of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue
in full force and effect.

 

(j)              This
Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by
different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

(k)             The
headings herein are for convenience only, do not constitute a part of this Subscription Agreement and shall not be deemed to limit
or affect any of the provisions hereof.

 

(l)              The
parties hereto agree that irreparable damage may occur in the event that the parties do not perform the provisions of this Subscription
Agreement in accordance with its terms or otherwise breach such provisions. Accordingly, the parties hereto acknowledge and agree
that the parties may be entitled to seek an injunction, specific performance and other equitable relief to prevent breaches of
this Subscription Agreement and to seek to enforce specifically the terms and provisions hereof, this being in addition to any
other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of
an injunction, specific performance or other equitable relief on the basis that the other party has an adequate remedy at law or
an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an injunction
or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the terms and provisions of this
Subscription Agreement shall not be required to provide any bond or other security in connection with any such order or injunction.

 

    	 	17	 

     

    

 

(m)            Any
notice or other communication required or permitted under this Subscription Agreement shall be in writing and shall be deemed to
have been given (i) when delivered by hand (with written confirmation of receipt), (ii) when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested), (iii) on the date sent by e-mail (with confirmation of transmission)
if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours of the
recipient, or (iv) when delivered by certified mail, registered mail, courier service, return-receipt received to the other party
at the address set forth below, or at such other address provided by like notice to the other party:

 

(i)          if
to Investor, the address specified on the signature page hereof, or

 

(ii)         if
to the Company, to:

 

c/o New Frontier
Corporation

23rd Floor,
299 QRC 

287-299 Queen’s
Road Central

Hong Kong

Attention:         Carl
Wu

E-mail:            carl@new-frontier.com

 

with a copy
(which shall not constitute notice) to:

 

Simpson Thacher & Bartlett
LLP

425 Lexington Avenue

New York, New
York 10017

Attention:         Patrick
J. Naughton

E-mail:            PNaughton@stblaw.com

 

Simpson Thacher & Bartlett
LLP

3901 China World Tower

1 Jianguomenwai Avenue

Beijing 100004, China

Attention:         Yang
Wang

E-mail:            yang.wang@stblaw.com

 

with a second
required copy (which shall not constitute notice) to:

 

Winston & Strawn LLP

200 Park Avenue

New York, NY 10166-4193

United States

Attention:        Joel
L. Rubinstein

Email:             JRubinstein@winston.com

 

(n)             This
Subscription Agreement shall be governed by, and construed in accordance with, the laws of the Hong Kong Special Administrative
Region (“Hong Kong”), without regard to the principles of conflicts of laws that would otherwise require the
application of the law of any other state.

 

    	 	18	 

     

    

 

(o)             The
parties agree that all disputes arising under, or relating to, this Subscription Agreement shall be resolved in accordance with
the ICC Rules of Arbitration by a panel of three arbitrators. The arbitration shall be seated in Hong Kong, although hearings may
take place anywhere that the arbitral tribunal deems convenient after consultation with the parties. The language of the proceedings
shall be English.

 

(p)             The
Company agrees to comply with any applicable “offering restrictions” within the meaning of Rule 902 under the Securities
Act with respect to any offers or sales of Class A Ordinary Shares made in reliance thereon.

 

[(q)           Investor
acknowledges that the Company will rely on the acknowledgments, understandings, agreements, representations and warranties contained
in this Subscription Agreement. Prior to the Closing, Investor agrees to promptly notify the Company if any of the acknowledgments,
understandings, agreements, representations and warranties of Investor set forth herein are no longer accurate in all material
respects. The Company acknowledges that Investor will rely on the acknowledgments, understandings, agreements, representations
and warranties contained in this Subscription Agreement. Prior to the Closing, the Company agrees to promptly notify Investor if
any of the acknowledgments, understandings, agreements, representations and warranties of the Company set forth herein are no longer
accurate in all material respects.]8

 

[SIGNATURE PAGES FOLLOW]

 

 

8 Included in the
subscription agreement for one investor.

  

    	 	19	 

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Subscription Agreement to be duly executed by its authorized signatory as of the date first indicated
above.

 

	 	NEW FRONTIER CORPORATION
	 	 	 
	 	By:	           
	 	 	Name: Carl Wu
	 	 	Title: Director
	 	 	 
	 	Address for notices:
	 	 	 
	 	23/F, 299 QRC
	 	 
	 	No. 287-299, Queen’s Rd Central
	 	 
	 	Hong Kong

 

     

     

    

  

IN WITNESS WHEREOF,
Investor has caused this Subscription Agreement to be duly executed by its authorized signatory as of the date first indicated
above.

 

	 	INVESTOR:
	 	 	 
	 	Name:	 
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	Address for notices:
	 	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

	 	Number of Subject Shares:                                     
	 	 
	 	Purchase Price per Subject Share: US $10.00
	 	 
	 	Aggregate Purchase Price: US$Exhibit 10.5

 

EXECUTION VERSION

 

AGREEMENT

 

This AGREEMENT, dated
as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein,
this “Agreement”), is made and entered into by and among:

 

		(a)	Vivo Capital Fund IX (Cayman), L.P., an exempted
limited partnership established under the laws of the Cayman Islands (“Vivo”);

 

		(b)	NEW FRONTIER PUBLIC HOLDING LTD., an exempted company incorporated with limited liability under
the laws of the Cayman Islands (the “Sponsor”);

 

		(c)	NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws
of the Cayman Islands (“NFC”);

 

		(d)	Antony Leung, an individual; and

 

		(e)	Carl Wu, an individual (together with Antony Leung,
the “Founders”).

 

Vivo, the Sponsor,
NFC and the Founders are sometimes individually referred to in this Agreement as a “Party” and collectively
as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the respective meanings
ascribed to such terms in the Transaction Agreement (defined below). Section 1.3 (Interpretation and Rules of Construction)
of the Transaction Agreement shall apply, mutatis mutandis, to this Agreement.

 

RECITALS

 

WHEREAS, NFC, certain
of its Subsidiaries, Healthy Harmony Holdings, L.P. and certain other parties propose to enter into certain transaction agreement,
dated on or about the date hereof (as may be amended, supplemented, modified and varied from time to time in accordance with the
terms herein, the “Transaction Agreement”, and the transactions contemplated therein, the “Acquisition
Transaction”) relating to a proposed business combination involving NFC, Healthy Harmony Holding, L.P. and/or their respective
affiliates to be effected on the terms and subject to the conditions set forth in the Transaction Agreement;

 

WHEREAS, Vivo and NFC
are entering into that certain Subscription Agreement on or about the date hereof (the “Vivo Subscription Agreement”),
pursuant to which Vivo will purchase, at the closing immediately prior to the consummation of the Acquisition Transaction (the
“Closing” and the date of the Closing, the “Closing Date”), certain NFC Class A Shares from
NFC through a private placement (the “Vivo Shares”); and

 

WHEREAS, as a condition
and a material inducement to Vivo’s purchase of the Vivo Shares, Vivo, the Sponsor, NFC and the Founders (each in his capacity
as a direct or indirect shareholder of the NFC) desire to enter into this Agreement;

 

NOW, THEREFORE, in
consideration of the foregoing and the respective representations, warranties, covenants, agreements and conditions set forth in
this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
Parties, intending to be legally bound hereby, hereby agree as follows:

 

    	 	 	 

     

    

  

ARTICLE I

Sell-down
AGREEMENT

 

Section 1.1           For
purposes of this Agreement,

 

“Equity Security”
means, with respect to any Person, any shares, partnership interests, membership interests, units or other equity securities, or
any options, warrants or other rights convertible, exercisable or exchangeable for any shares, partnership interests, membership
interests or other equity securities, of such Person.

 

“Founders
NFC Shares” means the aggregate number of the NFC Shares (without duplication) of each Founder on a Look-through Basis.

 

“Founders
Transfer Ratio” as of a specified time means a fraction, the numerator of which is the cumulative reductions in the Founders
NFC Shares after the consummation of the Acquisition Transaction through such specified time (disregarding any increases in the
Founders NFC Shares after the consummation of the Acquisition Transaction and any offsetting effect thereof), and the denominator
of which is the Founders NFC Shares as of immediately after the consummation of the Acquisition Transaction.

 

“Immediate
Subsidiary” of a Person means any other Person that is Controlled by the first-mentioned Person and in which the first-mentioned
Person holds any Equity Securities.

 

The NFC Shares of a
Person on a “Look-through Basis” means (i) the aggregate number of NFC Shares held by such Person (and, where
such Person is a natural Person, his Immediate Family Members), and (ii) the sum of (x) the number of NFC Shares of each Immediate
Subsidiary of such Person on a Look-through Basis, multiplied by (y) the percentage of the Equity Securities in such Immediate
Subsidiary that are held by such Person. For purposes hereof, an Equity Security is deemed to be “held” by a Person,
and such Person “holds” such Equity Security, if (i) it is recorded in the name of such Person and such Person has
not Transferred such Equity Security, or (ii) where such Person is a natural Person, if it is recorded in the name of any of his
Relevant Holders, and such Relevant Holder has not Transferred such Equity Security.

 

“Relevant
Holders” of a Person who is a natural Person means (i) such Person’s Immediate Family Members, (ii) trusts whose
beneficiaries are such Person and/or his Immediate Family Members, and (iii) other Persons who acquired the relevant Equity Securities
from such Person (or his estate) by virtue of laws of descent and distribution upon death of such Person or pursuant to a qualified
domestic relations order.

 

“Transfer”
and its derivatives mean (i) any direct or indirect offer, sale, lease, assignment, encumbrance, pledge, hypothecation, disposition
or other transfer (by operation of law or otherwise), either voluntary or involuntary, or entry into any contract, option or other
arrangement or understanding with respect to any offer, sale, lease, assignment, encumbrance, pledge, hypothecation, disposition
or other transfer (by operation of law or otherwise), of any share capital, Equity Security or interest in any share capital or
Equity Security, other than any transfer or series of transfers of an aggregate of up to 10% of the Founders NFC Shares as of the
date hereof to the employees of the Company or any of its Subsidiaries, or (ii) in respect of any share capital or Equity Security
or interest in any share capital or Equity Security, to enter into any swap or any other agreement, transaction or series of transactions
that hedges or transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of such share capital,
Equity Security or interest in any share capital or Equity Security, whether any such swap, agreement, transaction or series of
transactions is to be settled by delivery of securities, in cash or otherwise. “Transferor” means a Person who makes
or proposes to make a Transfer. “Transferee” means a Person to whom a Transfer is made or is proposed to be made. For
the avoidance of doubt, the entry into any voting agreement or arrangement in respect of any Equity Security shall not, in and
by itself, be deemed a Transfer for purposes hereof.

 

    	 	2	 

     

    

 

“Vivo NFC
Shares” means the aggregate number of the NFC Shares (without duplication) of Vivo on a Look-through Basis.

 

“Vivo Transfer
Ratio” as of a specified time means a fraction, the numerator of which is the cumulative reductions in the Vivo NFC Shares
after the consummation of the Acquisition Transaction through such specified time (disregarding any increases in the Vivo NFC Shares
after the consummation of the Acquisition Transaction and any offsetting effect thereof), and the denominator of which is the Vivo
NFC Shares as of immediately after the consummation of the Acquisition Transaction.

 

Section 1.2           Transfer
Restrictions.

 

(a)          During
the period commencing on the date hereof and ending on the Closing Date, without the prior written consent of Vivo, none of the
Founders or the Sponsor may, and each Founder shall procure its Relevant Holders and Controlled Affiliates to not, Transfer any
NFC Shares if such proposed Transfer would result in a reduction in the Founders NFC Shares.

 

(b)          From
and after the Closing Date and for so long as Vivo holds any Vivo Shares, without the prior written consent of Vivo, none of the
Founders or the Sponsor may, and each Founder shall procure its Relevant Holders and Controlled Affiliates to not, Transfer any
NFC Shares if such proposed Transfer would cause the Founders Transfer Ratio to exceed the Vivo Transfer Ratio as of immediately
after such Transfer.

 

Section 1.3           Documentation
and Information. Each of the Parties shall permit and hereby authorizes the other Parties and NFC, as the case may be, to publish
and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that such other
Parties and NFC, as applicable, determines to be necessary or desirable in connection with the Transaction Agreement, the Acquisition
Transaction, the Vivo Subscription Agreement, the Closing and this Agreement, Vivo’s identity, the ownership of the Vivo
NFC Shares and the Founders NFC Shares, as applicable, and the nature of each Party’s commitments and obligations under this
Agreement.

 

ARTICLE II

MISCELLANEOUS

 

Section 2.1           Termination.
This Agreement shall terminate automatically and become void and of no further force or effect, without any notice or other action
by any Person, upon the earliest to occur of (a) the fifth (5th) Business Day after written notice of termination by Vivo
to the other parties hereto, (b) the date on which the Vivo Transfer Ratio is 100%, (c) the date on which the Transaction Agreement
is terminated in accordance with its terms prior to the closing thereunder having taken place, and (d) subsequent to the consummation
of the Acquisition Transaction, the Company completes a liquidation, merger, share exchange or other similar transaction which
results in all of its shareholders having the right to exchange their NFC Shares for cash, securities or other property except
for any transaction where the NFC Shares outstanding immediately prior to such transaction are exchanged for securities representing,
immediately following such transaction, at least a majority of the voting power of the surviving or resulting company.

 

    	 	3	 

     

    

 

Section 2.2           Third
Party Beneficiaries. This Agreement is exclusively for the benefit of the Parties, and their respective successors and permitted
assigns, and this Agreement shall not be deemed to confer upon or give to any other third party any remedy, claim, liability, reimbursement,
cause of action or other right by virtue of any applicable law in any jurisdiction to enforce any of the terms to this Agreement.

 

Section 2.3           Governing
Law. This Agreement, and all claims or causes of action (whether in contract, tort or statute) or matters (including matters
of validity, construction, effect, performance and remedies) that may be based upon, arise out of or relate to this Agreement,
or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out
of or related to any representation or warranty made in or in connection with this Agreement) shall be governed by and construed
exclusively in accordance with the Laws of the Cayman Islands (without giving effect to any choice of law principles thereof that
would cause the application of the Laws of another jurisdiction).

 

Section 2.4           Dispute
Resolution. Any dispute, controversy or claim (including any dispute relating to the existence, validity, interpretation, performance,
breach or termination of this Agreement or any dispute regarding non-contractual obligations arising out of or relating to this
Agreement) shall be referred to and finally resolved in accordance with the ICC Rules of Arbitration by a panel of three arbitrators.
The arbitral award shall be final and binding upon all Parties. The seat of arbitration shall be in Hong Kong Special Administrative
Region (“Hong Kong”). The language of arbitration shall be English. The governing law of this arbitration clause
shall be the Laws of Hong Kong. The Parties agree that any award rendered by the arbitral tribunal may be enforced by any court
having jurisdiction over the Parties or over the Parties’ assets wherever the same may be located. To the extent that any
Party has or hereafter may acquire any immunity (sovereign or otherwise) from any legal action, suit or proceeding, from any jurisdiction
or any court or from set-off or any legal process (whether service or notice, attachment prior to judgment, execution of judgment
or otherwise) with respect to itself or any of its assets, whether or not held for its own account, such Party hereby irrevocably
and unconditionally waives and agrees not to plead or claim such immunity in any disputes, controversies or claims arising out
of or relating to this Agreement, including in any judicial proceedings ancillary to an arbitration hereunder, including without
limitation immunity from any judicial proceeding to compel arbitration, for interim relief in aid of arbitration, or to enforce
any arbitral award, immunity from service of process, immunity from jurisdiction of any court, and immunity of any of its property
from execution. Nothing in this Section 2.4 shall be construed as preventing any Party from seeking an injunction,
temporary restraining order or other equitable relief in any court of competent jurisdiction pursuant to Section 2.5
pending final determination of the dispute by the arbitral tribunal.

 

    	 	4	 

     

    

 

Section 2.5           Specific
Performance. The Parties hereto acknowledge that the rights of each Party to consummate the transactions contemplated hereby
are unique and recognize and affirm that in the event of a breach of this Agreement by any Party, money damages may be inadequate
and the non-breaching Party may have no adequate remedy at law. Accordingly, the Parties agree that such non-breaching Party shall
have the right to enforce its rights and the other Party’s obligations hereunder by an action or actions for specific performance
and/or injunctive relief (without posting of bond or other security), including any order, injunction or decree sought by such
non-breaching Party to cause the other Party to perform its/their respective agreements and covenants contained in this Agreement
and to cure breaches of this Agreement, without the necessity of proving actual harm and/or damages or posting a bond or other
security therefore. Each Party further agrees that the only permitted objection that it may raise in response to any action for
any such equitable relief is that it contests the existence of a breach or threatened breach of this Agreement.

 

Section 2.6           Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which taken together
shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile
or e-mail shall be as effective as delivery of a manually executed counterpart of this Agreement.

 

Section 2.7           Amendments.
This Agreement may be amended, modified or supplemented at any time only by the written consent of all of the Parties, and any
amendment, modification or supplement so effected shall be binding on all of the Parties.

 

Section 2.8           Capacity
as Shareholder. Each Founder signs this Agreement solely in his capacity as a direct or indirect shareholder of NFC, and not
in his capacity as a director, officer or employee of NFC or in his capacity as a trustee or fiduciary of any employee benefit
plan or trust. Nothing in this Agreement shall be construed to impose any obligation or limitation on votes or actions taken by
any director, officer, employee, agent or other representative of NFC in his or her capacity as such.

 

Section 2.9           Further
Assurances. Each of the Parties shall execute such documents and perform such further acts as may be reasonably required to
carry out the provisions hereof and the actions contemplated hereby.

 

Section 2.10         Severability.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the transactions contemplated by this Agreement is not affected in any manner materially
adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced,
the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely
as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as originally
contemplated to the fullest extent possible.

 

Section 2.11         Entire
Agreement. This Agreement and the Vivo Subscription Agreement constitute the entire agreement among the Parties with respect
to the subject matter of this Agreement and supersede all other prior agreements and understandings, both written and oral, between
the Parties with respect to the subject matter of this Agreement, including Section 12(g) of the Vivo Subscription Agreement.

 

Section 2.12         Notice.
All notices, requests and other communications to any Party shall be in writing (including facsimile transmission) and shall be
given (a) when actually delivered in person or by e-mail, (b) on the next Business Day when sent by overnight courier, or (c) on
the second succeeding Business Day when sent by registered or certified mail (postage prepaid, return receipt requested), in each
case, to such Party’s address set forth on a signature page hereto, or to such other address as such Party may hereafter
specify in writing to the other Parties for such purpose.

 

    	 	5	 

     

    

 

Section 2.13         Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

[REMAINDER
OF THIS PAGE LEFT INTENTIONALLY BLANK]

 

    	 	6	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as a deed as of the date first written above.

 

	SIGNED and DELIVERED as a DEED	)
	by Vivo Capital Fund IX (Cayman), L.P.	)
	By: Vivo Capital IX (Cayman), LLC, General Partner	)

 

	By:	/s/ Frank Kung	 
	Name: Frank Kung	 
	Title: Managing Member	 

 

in the presence of:

 

	Name:	/s/ Peiyi Zhao	 
		Peiyi Zhao
	 	 
	Address:	c/o Vivo Capital LLC
	 	192 Lytton Avenue
	 	Palo Alto, CA 94301
	 	 
	 	with a copy (which shall not constitute notice) to:

 

	 	Sidley Austin LLP
	 	1001 Page Mill Road
	 	Building 1
	 	Palo Alto, CA 94304

	 	Attention:	Ruchun Ji
	 	E-mail:	rji@sidley.com

 

[Project Unicorn—Signature Page
to Agreement] 

 

    	 	 	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as a deed as of the date first written above.

 

	SIGNED as a DEED	)
	by NEW FRONTIER PUBLIC HOLDING LTD.	)

 

	By:	/s/ Carl Wu	 
	Name: Carl Wu	 
	Title: Director	 

 

in the presence of:

 

	Name:	/s/ Yue Chen	 
	 	Yue Chen
	 	 
	Address:	23/F QRC 299, No. 287-299
	 	Queen’s Road Central
	 	Hong Kong

 

[Project Unicorn—Signature Page
to Agreement] 

 

    	 	 	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as a deed as of the date first written above.

 

	SIGNED as a DEED	)
	by NEW FRONTIER CORPORATION	)

 

	By:	/s/ Carl Wu	 
	Name: Carl Wu	 
	Title: Director	 

 

in the presence of:

 

	Name:	/s/ Yue Chen	 
	 	Yue Chen
	 	 
	Address:	23/F QRC 299, No. 287-299
	 	Queen’s Road Central
	 	Hong Kong

 

[Project Unicorn—Signature Page
to Agreement] 

 

    	 	 	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as a deed as of the date first written above.

 

	SIGNED and DELIVERED as a DEED	)
	by ANTONY LEUNG	)

 

	/s/ Antony Leung	 
	Name: Antony Leung	 

 

in the presence of:

 

	Name:	/s/ Yue Chen	 
	 	Yue Chen
	 	 
	Address:	23/F QRC 299, No. 287-299
	 	Queen’s Road Central
	 	Hong Kong

 

[Project Unicorn—Signature Page
to Agreement] 

 

    	 	 	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Agreement as a deed as of the date first written above.

 

	SIGNED and DELIVERED as a DEED	)
	by CARL WU	)

 

	/s/ Carl Wu	 
	Name: Carl Wu	 

 

in the presence of:

 

	Name:	/s/ Yue Chen	 
	 	Yue Chen
	 	 
	Address:	23/F QRC 299, No. 287-299
	 	Queen’s Road Central
	 	Hong Kong

 

[Project Unicorn—Signature Page
to Vivo Side Letter]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]